Q2 2025 USANA Health Sciences Inc Earnings Call Transcript
Key Points
- Usana Health Sciences Inc (USNA) reported an 11% year-over-year increase in consolidated net sales for the second quarter.
- Adjusted earnings per share rose by 36% compared to the previous year.
- The company successfully repaid its line of credit and ended the quarter debt-free with $151 million in cash.
- Strategic initiatives are being implemented to strengthen partnerships with brand partners and accelerate product innovation.
- Acquired businesses like Hiya and Rise Bar showed strong performance, contributing to diversification and financial strength.
- There was a decline in the overall active customer count during the second quarter.
- Economic uncertainty, particularly in China, poses potential risks to future performance.
- Upcoming changes in the compensation program led to some reservation and decreased acquisition in the latter half of the quarter.
- Short-term pressure on operating margins is anticipated due to investments in global conventions and product launches.
- Tariff uncertainties, especially concerning cross-border goods to China, could impact future business operations.
Good morning and welcome to the USANA Health Sciences Second Quarter Earnings Call. At this time, all participants are in a listen-only mode. (Operator Instructions)
I will now turn the conference over to your host, Andrew Masuda, Director of Investor Relations.
Thank you. You may begin.
Thanks, Diego, and good morning, everyone. We appreciate you joining us to review our second quarter results. Todayâs conference call is being broadcast live via web webcast and can be accessed directly from our website at ir.usana.com.
Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward looking statements regarding future events or the future financial performance of our company.
Those statements involve risks and uncertainties that could cause actual results to differ, perhaps materially, from the results projected in such forward looking statements. Examples of these
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
